THE USE OF ANTISENSE OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS - A REVIEW

Authors
Citation
Mr. Bennett, THE USE OF ANTISENSE OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS - A REVIEW, Journal of drug development and clinical practice, 7(3), 1995, pp. 225-235
Citations number
NO
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
13579215
Volume
7
Issue
3
Year of publication
1995
Pages
225 - 235
Database
ISI
SICI code
1357-9215(1995)7:3<225:TUOAOA>2.0.ZU;2-A
Abstract
Antisense oligonucleotides are synthetic nucleotide sequences designed to inhibit the expression of a single mRNA species. The increasing id entification of genes associated with disease, and the failure of some forms of conventional pharmacological agents, has prompted the therap eutic use of antisense oligonucleotides. Whilst this approach holds gr eet promise, particularly for diseases in which there is expression of unique gene sequences, considerable care is required in the design, s ynthesis and administration of antisense oligonucleotides in this cont ext. This review summarises the concerns regarding the potential role of antisense oligonucleotides as therapeutic agents.